Riskpilot← Back to searchSign inGet full accessNORENGROS HX AS
ASActiveOrg 821807182Fyrstikkalléen 3, 0661 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20189 employees
Revenue 2024
NOK 33,5M
+33% vs 2023
EBITDA margin
-1.0%
-152% vs 2023
Equity ratio
25.1%
Financial strength
Net profit 2024
NOK -504K
-252% vs 2023
| Revenue | NOK 33,5M | +33% |
| EBITDA | NOK -337K | -152% |
| Net profit | NOK -504K | -252% |
| Total assets | NOK 9M | +9% |
| Equity | NOK 2,2M | -18% |
| Employees | 9 | — |
Legal name
NORENGROS HX AS
Org number
821807182
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17. desember 2018
Share capital
NOK 3 000 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drive handel med medisinsk tekniske produkter og alt som står i forbindelse hermed, til beste for norengroskjeden.
Address
Fyrstikkalléen 3, 0661 Oslo
Phone
+4722660990
Email
hs@norengros.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 031 | 15 320 | 15 602 | 25 118 | 33 516 |
| Staff expenses | −1 334 | −2 765 | −3 169 | −4 402 | −6 239 |
| EBITDA | −1 265 | 212 | 369 | 650 | −337 |
| Depreciation & amort. | −172 | −171 | −136 | −117 | −156 |
| EBIT | −1 437 | 41 | 234 | 532 | −493 |
| Net financials | −40 | −20 | −30 | −98 | −144 |
| Profit before tax | −1 476 | 20 | 204 | 435 | −638 |
| Tax | −325 | 6 | 47 | 102 | −134 |
| Net profit | −1 152 | 15 | 157 | 332 | −504 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 377 | 6 100 | 5 097 | 8 251 | 8 953 |
| Equity | 2 244 | 2 259 | 2 416 | 2 748 | 2 245 |
| Long-term debt | 0 | 850 | 708 | 566 | 741 |
| Short-term debt | 3 133 | 2 992 | 1 973 | 4 937 | 5 968 |
| Total debt | 3 133 | 3 841 | 2 681 | 5 503 | 6 709 |
EBITDA margin
-1.0%
This company
15.8%
Market median
-106% vs market
20202024
Equity ratio
25.1%
This company
38.2%
Market median
-34% vs market
20202024
Return on equity
-22.4%
This company
18.4%
Market median
-222% vs market
20202024
Net profit margin
-1.5%
This company
8.1%
Market median
-119% vs market
20202024
Asset turnover
3.74×
This company
1.12×
Market median
+234% vs market
20202024
Debt / equity
2.99×
This company
0.62×
Market median
-382% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JI Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Former (2) | ||
| Board of Directors | 2019 – 2025 | |
| Board of Directors | 2019 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 14.42% | 14.42% | 2024 | |
| Company | 14.4% | 14.4% | 2024 | |
| Company | 12.52% | 12.52% | 2024 | |
| Company | 11.67% | 11.67% | 2024 | |
| Company | 10.42% | 10.42% | 2024 | |
| Company | 10% | 10% | 2024 | |
| Company | 5% | 5% | 2024 | |
| Company | 5% | 5% | 2024 | |
| Company | 4.92% | 4.92% | 2024 | |
| Company | 4.83% | 4.83% | 2024 | |
| Company | 4.17% | 4.17% | 2024 | |
| Company | 1.67% | 1.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Erik Tanche Nilssen Invest As
NORENGROS HX AS Board members of NORENGROS HX AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Ivarson | Chief Executive Officer | 0 companies |
| Lise Andrea Setterberg Nossen | Board of Directors | 0 companies |
| Morten Solheim Furseth | Board of Directors | 0 companies |
| Ruth Vigdis Brusdal | Board of Directors | 0 companies |
| Hanne Martine Vedeler | Board of Directors | 0 companies |
| Gunnstein Kjosavik | Board of Directors | 0 companies |
| Camilla Skog Rodal | Chairman | 0 companies |